Hypertriglyceridemia and decreased high-density lipoprotein could be a clue for visceral leishmaniasis

Infectious Diseases in Clinical Practice

Volumn 14, Issue 6, 2006, Pages 401-402

  Seçmeer, Gülten ^a   Cengiz, A Bülent ^a   Gürgey, Aytemiz ^a   Kara, Ates ^a   Cultu, Oge ^a   Tavil, Betul ^a   Devrim, Ilker ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ABDOMINAL DISTENSION; ARTICLE; CASE REPORT; CHOLESTEROL BLOOD LEVEL; HEPATOMEGALY; HUMAN; HYPERTRIGLYCERIDEMIA; LEISHMANIA; MALE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; SCHOOL CHILD; SPLENOMEGALY; TRIACYLGLYCEROL BLOOD LEVEL; VISCERAL LEISHMANIASIS;

EID: 33845244832     PISSN: 10569103     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.idc.0000219053.50922.99     Document Type: Article

References (9)

1. Kafetzis DA. An overview of paediatric leishmaniasis. J Postgrad Med. 2003;49:31-38.
2. Guerin PJ, Olliaro P, Sundar S, et al. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494-501.
3. Murray HW. Kala-Azar - progress against a neglected disease. N Engl J Med. 2002;347:1793-1794.
4. Bekaert ED, Kallel R, Bouma M-E, et al. Plasma lipoproteins in infantile visceral leishmaniasis: deficiency of apolipoproteins A-I and A-II. Clin Chim Acta. 1989;184:181-192.
5. Bekaert ED, Dole E, Dubois DY, et al. Alterations in lipoprotein density classes in infantile visceral leishmaniasis: presence of apolipoprotein SAA. Eur J Clin Invest. 1992;22:190-199.
6. Liberopoulos E, Alexandridis G, Bairaktari E, et al. Severe hypocholesterolemia with reduced serum lipoprotein(a) in a patient with visceral leishmaniasis. Ann Clin Lab Sci. 2002;32:305-308.
7. Erdeve O, Dallar Y, Siklar Z. Is hypertriglyceridaemia a new concept for visceral leishmaniasis? Ann Trop Paediatr. 2004;24:369.
8. Khovidhunkit W, Memon RA, Feingold KR, et al. Infection and inflammation-induced proatherogenic changes of lipoproteins. J Infect Dis. 2000;181(suppl 3):S462-S472.
9. Sammalkorpi K, Valtonen V, Kerttula Y, et al. Changes in serum lipoprotein pattern induced by acute infections. Metabolism. 1988;37:859-865.